KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Revenue (2016 - 2025)

Idexx Laboratories has reported Revenue over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Revenue at $1.1 billion for Q4 2025, up 14.28% from a year ago — trailing twelve months through Dec 2025 was $4.3 billion (up 10.42% YoY), and the annual figure for FY2025 was $4.3 billion, up 10.42%.
  • Revenue for Q4 2025 was $1.1 billion at Idexx Laboratories, down from $1.1 billion in the prior quarter.
  • Over the last five years, Revenue for IDXX hit a ceiling of $1.1 billion in Q2 2025 and a floor of $777.7 million in Q1 2021.
  • Median Revenue over the past 5 years was $908.6 million (2023), compared with a mean of $922.2 million.
  • Biggest five-year swings in Revenue: increased 29.57% in 2021 and later increased 3.43% in 2022.
  • Idexx Laboratories' Revenue stood at $801.1 million in 2021, then grew by 3.43% to $828.6 million in 2022, then grew by 8.81% to $901.6 million in 2023, then increased by 5.84% to $954.3 million in 2024, then grew by 14.28% to $1.1 billion in 2025.
  • The last three reported values for Revenue were $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.